In mice, Bifidobacterium breve was shown to effectively induce the Regenerating islet-derived III (REGIII; one class of antimicrobials protein expressed in the intestine) production via the MyD88-Ticam1 pathway, demonstrating that this probiotic may enhance the mucosal barrier and protect the host from infection and inflammation89. Here, TICAM1 is linked to infection.